SINGAPORE, Feb. 27, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U

TAMPA, Fla., Feb. 27, 2020 /PRNewswire/ -- Invo Behavior and Therapy Services today announced that it has opened children's therapy centers in Tampa, St. Petersburg and Riverview. The new centers will serve more than 200 area children, significantly expanding the avail

OMAHA, Neb., Feb. 27, 2020 /PRNewswire/ -- Senior Vision Services, a leading provider of optometry in long-term care communities (LTCCs), has been acquired by Senior Dental Care, the leading provider of oral care and dental insurance to LTCCs.Senior Vision Services delivers portable, full-service optometry to residents of LTCCs.  T

MINNEAPOLIS, Feb. 27, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2020 at 9:30 a.m. EST. The conference wi

STAINES-UPON-THAMES, United Kingdom, Feb. 27, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it will p

DUBLIN, Feb. 27, 2020 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-Care Products™", today announced financial results for the fourth quarter and fiscal year ended December 31, 2019.

STAMFORD, Conn., Feb. 27, 2020 /PRNewswire/ -- According to the Centers for Disease Control and Prevention, Medicare spent

MIAMI, Feb. 27, 2020 /PRNewswire/ -- Anatomy, South Florida's premier health and wellness brand, has tapped Strategy and Marketing veteran David Geller to lead the company's business, operations and growth strategies as the newly appointed Chief Operating Officer (COO). Aligning with Anatomy's mission to establish integrate

PALO ALTO, Calif., Feb. 27, 2020 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, announced today that management will present at the following upcoming investor conferences:Cowen 40th Annual Health Care Confere

KRAKOW, Poland, Feb. 27, 2020 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, today announced that data from its multiple oncology programs will be presented at the American Association for Cancer Research (AA